A citation-based method for searching scientific literature

Daniel J Weisenberger, Kimberly D Siegmund, Mihaela Campan, Joanne Young, Tiffany I Long, Mark A Faasse, Gyeong Hoon Kang, Martin Widschwendter, Deborah Weener, Daniel Buchanan, Hoey Koh, Lisa Simms, Melissa Barker, Barbara Leggett, Joan Levine, Myungjin Kim, Amy J French, Stephen N Thibodeau, Jeremy Jass, Robert Haile, Peter W Laird. Nat Genet 2006
Times Cited: 1336







List of co-cited articles
1009 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
25

The consensus molecular subtypes of colorectal cancer.
Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien de Reyniès, Andreas Schlicker, Charlotte Soneson, Laetitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino,[...]. Nat Med 2015
23

CpG island methylator phenotype in colorectal cancer.
M Toyota, N Ahuja, M Ohe-Toyota, J G Herman, S B Baylin, J P Issa. Proc Natl Acad Sci U S A 1999
23

A genetic model for colorectal tumorigenesis.
E R Fearon, B Vogelstein. Cell 1990
20

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C R Boland, S N Thibodeau, S R Hamilton, D Sidransky, J R Eshleman, R W Burt, S J Meltzer, M A Rodriguez-Bigas, R Fodde, G N Ranzani,[...]. Cancer Res 1998
18

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
17

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.
Michael J Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz-Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill,[...]. J Clin Oncol 2018
751
16

Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.
Sabine Venderbosch, Iris D Nagtegaal, Tim S Maughan, Christopher G Smith, Jeremy P Cheadle, David Fisher, Richard Kaplan, Philip Quirke, Matthew T Seymour, Susan D Richman,[...]. Clin Cancer Res 2014
329
14

Microsatellite instability in colorectal cancer.
C Richard Boland, Ajay Goel. Gastroenterology 2010
13

Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.
Wade S Samowitz, Hans Albertsen, Jennifer Herrick, Theodore R Levin, Carol Sweeney, Maureen A Murtaugh, Roger K Wolff, Martha L Slattery. Gastroenterology 2005
427
11

Role of the serrated pathway in colorectal cancer pathogenesis.
Barbara Leggett, Vicki Whitehall. Gastroenterology 2010
617
11

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.
Y Y Juo, F M Johnston, D Y Zhang, H H Juo, H Wang, E P Pappou, T Yu, H Easwaran, S Baylin, M van Engeland,[...]. Ann Oncol 2014
110
11

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Michael J Overman, Ray McDermott, Joseph L Leach, Sara Lonardi, Heinz-Josef Lenz, Michael A Morse, Jayesh Desai, Andrew Hill, Michael Axelson, Rebecca A Moss,[...]. Lancet Oncol 2017
11

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
Scott Kopetz, Axel Grothey, Rona Yaeger, Eric Van Cutsem, Jayesh Desai, Takayuki Yoshino, Harpreet Wasan, Fortunato Ciardiello, Fotios Loupakis, Yong Sang Hong,[...]. N Engl J Med 2019
373
11

BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
T Kambara, L A Simms, V L J Whitehall, K J Spring, C V A Wynter, M D Walsh, M A Barker, S Arnold, A McGivern, N Matsubara,[...]. Gut 2004
542
10

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.
Paul Lochhead, Aya Kuchiba, Yu Imamura, Xiaoyun Liao, Mai Yamauchi, Reiko Nishihara, Zhi Rong Qian, Teppei Morikawa, Jeanne Shen, Jeffrey A Meyerhardt,[...]. J Natl Cancer Inst 2013
285
10

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
Shuji Ogino, Katsuhiko Nosho, Gregory J Kirkner, Takako Kawasaki, Jeffrey A Meyerhardt, Massimo Loda, Edward L Giovannucci, Charles S Fuchs. Gut 2009
565
10

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans, George Fountzilas, Konstantine T Kalogeras, Vassiliki Kotoula, Demetris Papamichael, Pierre Laurent-Puig,[...]. Lancet Oncol 2010
10

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
E Van Cutsem, A Cervantes, R Adam, A Sobrero, J H Van Krieken, D Aderka, E Aranda Aguilar, A Bardelli, A Benson, G Bodoky,[...]. Ann Oncol 2016
10

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
9

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
9

Genetic alterations during colorectal-tumor development.
B Vogelstein, E R Fearon, S R Hamilton, S E Kern, A C Preisinger, M Leppert, Y Nakamura, R White, A M Smits, J L Bos. N Engl J Med 1988
9

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
Thierry André, Kai-Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis Punt, Denis Smith, Rocio Garcia-Carbonero, Manuel Benavides, Peter Gibbs,[...]. N Engl J Med 2020
265
9

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
Christine M Ribic, Daniel J Sargent, Malcolm J Moore, Stephen N Thibodeau, Amy J French, Richard M Goldberg, Stanley R Hamilton, Pierre Laurent-Puig, Robert Gryfe, Lois E Shepherd,[...]. N Engl J Med 2003
8

Genome-scale analysis of aberrant DNA methylation in colorectal cancer.
Toshinori Hinoue, Daniel J Weisenberger, Christopher P E Lange, Hui Shen, Hyang-Min Byun, David Van Den Berg, Simeen Malik, Fei Pan, Houtan Noushmehr, Cornelis M van Dijk,[...]. Genome Res 2012
425
8

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
Scott Kopetz, Jayesh Desai, Emily Chan, Joel Randolph Hecht, Peter J O'Dwyer, Dipen Maru, Van Morris, Filip Janku, Arvind Dasari, Woonbook Chung,[...]. J Clin Oncol 2015
365
8

Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
Michael J O'Brien, Shi Yang, Charline Mack, Huihong Xu, Christopher S Huang, Elizabeth Mulcahy, Mark Amorosino, Francis A Farraye. Am J Surg Pathol 2006
371
8

Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.
Harith Rajagopalan, Alberto Bardelli, Christoph Lengauer, Kenneth W Kinzler, Bert Vogelstein, Victor E Velculescu. Nature 2002
957
8

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
8

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.
Eric Van Cutsem, Claus-Henning Köhne, István Láng, Gunnar Folprecht, Marek P Nowacki, Stefano Cascinu, Igor Shchepotin, Joan Maurel, David Cunningham, Sabine Tejpar,[...]. J Clin Oncol 2011
8

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
Jean-Yves Douillard, Kelly S Oliner, Salvatore Siena, Josep Tabernero, Ronald Burkes, Mario Barugel, Yves Humblet, Gyorgy Bodoky, David Cunningham, Jacek Jassem,[...]. N Engl J Med 2013
8

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.
Ryan B Corcoran, Thierry André, Chloe E Atreya, Jan H M Schellens, Takayuki Yoshino, Johanna C Bendell, Antoine Hollebecque, Autumn J McRee, Salvatore Siena, Gary Middleton,[...]. Cancer Discov 2018
239
8

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
Federica Di Nicolantonio, Miriam Martini, Francesca Molinari, Andrea Sartore-Bianchi, Sabrina Arena, Piercarlo Saletti, Sara De Dosso, Luca Mazzucchelli, Milo Frattini, Salvatore Siena,[...]. J Clin Oncol 2008
8

Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.
Jeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, Alexa B Schrock, Andrew Rankin, Ben Y Zhang, Pashtoon M Kasi, Jesse S Voss, Alexis D Leal, James Sun,[...]. J Clin Oncol 2017
154
8

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
David M Hyman, Igor Puzanov, Vivek Subbiah, Jason E Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S Raje, Eli L Diamond, Antoine Hollebecque,[...]. N Engl J Med 2015
7

Multitarget stool DNA testing for colorectal-cancer screening.
Thomas F Imperiale, David F Ransohoff, Steven H Itzkowitz, Theodore R Levin, Philip Lavin, Graham P Lidgard, David A Ahlquist, Barry M Berger. N Engl J Med 2014
796
7

Genomic and epigenetic instability in colorectal cancer pathogenesis.
William M Grady, John M Carethers. Gastroenterology 2008
594
7

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
Timothy Robert Church, Michael Wandell, Catherine Lofton-Day, Steven J Mongin, Matthias Burger, Shannon R Payne, Esmeralda Castaños-Vélez, Brent A Blumenstein, Thomas Rösch, Neal Osborn,[...]. Gut 2014
402
7

DNA methylation biomarkers for blood-based colorectal cancer screening.
Catherine Lofton-Day, Fabian Model, Theo Devos, Reimo Tetzner, Juergen Distler, Matthias Schuster, Xiaoling Song, Ralf Lesche, Volker Liebenberg, Matthias Ebert,[...]. Clin Chem 2008
319
7


Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.
Anirudh Prahallad, Chong Sun, Sidong Huang, Federica Di Nicolantonio, Ramon Salazar, Davide Zecchin, Roderick L Beijersbergen, Alberto Bardelli, René Bernards. Nature 2012
7

Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia.
Catherine E Bond, Cheng Liu, Futoshi Kawamata, Diane M McKeone, Winnie Fernando, Saara Jamieson, Sally-Ann Pearson, Alexandra Kane, Susan L Woods, Tamsin R M Lannagan,[...]. Epigenetics 2018
31
22

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer.
Ben Tran, Scott Kopetz, Jeanne Tie, Peter Gibbs, Zhi-Qin Jiang, Christopher H Lieu, Atin Agarwal, Dipen M Maru, Oliver Sieber, Jayesh Desai. Cancer 2011
435
7

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
Thierry André, Armand de Gramont, Dewi Vernerey, Benoist Chibaudel, Franck Bonnetain, Annemilaï Tijeras-Raballand, Aurelie Scriva, Tamas Hickish, Josep Tabernero, Jean Luc Van Laethem,[...]. J Clin Oncol 2015
303
7

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, Stephen N Thibodeau, Roberto Labianca, Stanley R Hamilton, Amy J French, Brian Kabat, Nathan R Foster, Valter Torri,[...]. J Clin Oncol 2010
901
7

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.
Arnaud D Roth, Sabine Tejpar, Mauro Delorenzi, Pu Yan, Roberto Fiocca, Dirk Klingbiel, Daniel Dietrich, Bart Biesmans, György Bodoky, Carlo Barone,[...]. J Clin Oncol 2010
818
7

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.
Shuji Ogino, Takako Kawasaki, Gregory J Kirkner, Peter Kraft, Massimo Loda, Charles S Fuchs. J Mol Diagn 2007
264
7

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.
S Ogino, M Cantor, T Kawasaki, M Brahmandam, G J Kirkner, D J Weisenberger, M Campan, P W Laird, M Loda, C S Fuchs. Gut 2006
265
7

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer.
M Koopman, G A M Kortman, L Mekenkamp, M J L Ligtenberg, N Hoogerbrugge, N F Antonini, C J A Punt, J H J M van Krieken. Br J Cancer 2009
247
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.